Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TRYP Therapeutics Inc C.TRYP

Healthcare
Tryp Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric... see more

Bullboard (CSE:TRYP)

View:
Prev 1 2 3 4 5 6 Next
Post by yopmemama021on Jul 20, 2021 4:16pm

TRYP

  $TRYP $TRYPF   Looking forward to an update on all the work TRYP’s been doing in with the Universities of Michigan and Florida  at the Q3 Investor day they are hosting -July ...more  
137
Post by StockHawk1on Jul 19, 2021 4:03pm

New USA Today article by TRYP

Tryp Therapeutics ( $TRYPF, $TRYP ) develops psilocybin based treatments for neuropsychiatric disorders, including fibromyalgia and hypothalamic obesity, chronic pain and phantom limb The ability ...more  
114
Post by yopmemama021on Jul 16, 2021 5:29pm

TRYP

 TRYP closed green at $0.53, market cap $35.15 following yesterdays news that they will host Q3 investor Day later this month   - July 29th 2021- 9:00 am PDT-   TRYP will give a ...more  
126
Post by SkywalkerofLukeon Jul 15, 2021 7:02pm

$TRYP News

$TRYP just announced that it will host their Q3 Investor Day on July 29, 2021 at 9:00 a.m. PDT. Event will include a presentation by $TRYP ‘s management team to discuss - Updates on its ...more  
120
Post by StockHawk1on Jul 15, 2021 3:54pm

Q3 investors day, online, July 29th @ 9:00am PST

Tryp Therapeutics ( $TRYP ) is a pharmaceutical company focused on developing psilocybin-based compounds. One of their products is in phase 2 of clinical trials to see if it helps fibromyalgia and ...more  
89
Post by SkywalkerofLukeon Jun 17, 2021 5:06pm

Interview with $TRYP CEO

Check out this interview with the CEO of $TRYP Greg McKee on the Stock2Me Podcast.  Throughout the interview, McKee discussed the company’s prospective patients and targeted ailments, the need ...more  
151
Discussion
Post by yopmemama021on Jun 10, 2021 6:51pm

TRYP

  $TRYP   A Small study by British scientists found that psilocybin may be at least as effective as antidepressants and could help people suffering from severe depression into ...more  
125
Post by Batemanwanabeon Jun 08, 2021 1:52pm

Rvvtf

https://apple.news/AGzvqWpqMRtucgAWaqzAdPQ
92
Post by Swedeprofon Jun 08, 2021 1:12pm

TRYP Conference and Analyst Fire-side Chat

Digging this analyst fireside chat. These are the type of groups that can have big influence on a stock! Tryp Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference. Greg McKee ...more  
83
Post by maysilverstoneon Jun 03, 2021 4:52pm

$TRYP Disrupting the Psychedelic sector

  What I love about $TRYP is that they focus on developing psychedelic-based treatments for those suffering from rare neuropathic disorders, chronic pain disorders, and eating disorders ...more  
105
Post by maysilverstoneon Jun 01, 2021 4:39pm

$TRYP well positioned to be a leader in psychedelic's

$TRYP steady at $0.66, undervalued IMO with a mc of only $43.77M.   They recently announced that they have partnered with Alcami Corporation to support the proprietary formulation of ...more  
73
Post by maysilverstoneon May 28, 2021 3:52pm

$TRYP

$TRYP holding steady at $0.67. I'm personally very bullish on the psychedelic sector (projected to reach USD $10.75B by 2027) and I think this one has huge potential with a mc of only $44.43M.  ...more  
91
Post by Ltopolewon May 27, 2021 2:31pm

$TRYP Breakdown

Following the news that the cannabis industry titan, GW Pharmaceuticals, was acquired by Jazz Pharmaceuticals for $7.2 billion, many are wondering what this means for the potential growth in similar ...more  
187
Post by Ltopolewon May 25, 2021 3:47pm

$TRYP Announcement

$TRYP just announced an agreement with Alcami Corporation, a global pharmaceutical contract development and manufacturing organization, to support the proprietary formulation of products for $TRYP ‘s ...more  
72
Post by Ltopolewon May 21, 2021 2:56pm

Article on $TRYP

Check out this article about $TRYP and how they are currently changing the healthcare landscape with their research in psychedelics.  Over decades, people have been conditioned to the stigma ...more  
82
Prev 1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities